Jürgen Gallinat Selected Research

Psilocybin (Psilocibin)

7/2017

[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Gallinat Research Topics

Disease

43	Schizophrenia (Dementia Praecox) 12/2020 - 07/2003
8	Mental Disorders (Mental Disorder) 01/2021 - 01/2004
7	Alcoholism (Alcohol Abuse) 01/2022 - 11/2003
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022 - 12/2008
5	Bipolar Disorder (Manic Depressive Psychosis) 08/2015 - 06/2005
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 12/2007
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 03/2015
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2015
4	Substance-Related Disorders (Drug Abuse) 01/2018 - 12/2006
4	Tobacco Use Disorder (Nicotine Dependence) 01/2012 - 09/2007
3	Mood Disorders (Mood Disorder) 02/2022 - 04/2004
3	Autistic Disorder (Autism) 12/2020 - 01/2016
2	Autism Spectrum Disorder 01/2021 - 12/2020
2	Catatonia 01/2021 - 12/2020
2	Anxiety Disorders (Anxiety Disorder) 12/2020 - 05/2017
2	Body Weight (Weight, Body) 01/2013 - 06/2011
2	Panic Disorder (Panic Attack) 07/2011 - 04/2010
2	Anhedonia 03/2008 - 08/2006
1	Tourette Syndrome (Tourette's Syndrome) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Syndrome (Syndromes) 12/2020
1	Feeding and Eating Disorders (Eating Disorder) 12/2020
1	Chronic Disease (Chronic Diseases) 02/2020
1	Cognitive Dysfunction 01/2020
1	Parkinsonian Disorders (Parkinsonism) 11/2019
1	Amyloid Plaque 08/2018
1	Hallucinations (Hallucination) 01/2018
1	Pain (Aches) 01/2017
1	Cluster Headache (Cluster Headaches) 03/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Infections 05/2014
1	Obesity 01/2013
1	Antisocial Personality Disorder (Antisocial Personality) 08/2010
1	Marijuana Abuse (Cannabis Abuse) 05/2007

Drug/Important Bio-Agent (IBA)

10	Glutamic Acid (Glutamate)FDA Link 01/2020 - 10/2010
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 07/2011
7	Pharmaceutical PreparationsIBA 01/2017 - 12/2006
6	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 07/2003
5	Biological ProductsIBA 02/2020 - 02/2005
5	Antipsychotic Agents (Antipsychotics)IBA 11/2018 - 08/2006
5	Nicotine FDA Link 10/2011 - 12/2006
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2010 - 04/2004
3	Oxytocin (Pitocin)FDA LinkGeneric 01/2020 - 09/2013
3	Protons (Proton)IBA 01/2020 - 09/2011
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 01/2018
3	Ketamine FDA LinkGeneric 01/2019 - 01/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 11/2003
3	EndocannabinoidsIBA 08/2016 - 05/2007
3	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2010 - 01/2004
2	AutoantibodiesIBA 01/2021 - 12/2020
2	Oxytocin Receptors (Oxytocin Receptor)IBA 09/2013 - 01/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2013 - 12/2010
2	Neuropeptide YIBA 01/2013 - 01/2012
2	N-acetylaspartate (N-acetyl aspartate)IBA 10/2010 - 01/2010
2	CannabinoidsIBA 08/2009 - 08/2008
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 07/2009 - 03/2008
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 03/2008 - 12/2006
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Amyloid (Amyloid Fibrils)IBA 08/2018
1	SilverIBA 08/2018
1	Lysergic Acid Diethylamide (LSD)IBA 07/2017
1	Psilocybin (Psilocibin)IBA 07/2017
1	Psychotropic Drugs (Psychoactive Drugs)IBA 07/2017
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 07/2017
1	Glutathione (Reduced Glutathione)IBA 05/2017
1	Glutamine (L-Glutamine)FDA Link 05/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Inosine Monophosphate (IMP)IBA 11/2015
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 06/2015
1	Hallucinogens (Psychedelics)IBA 03/2015
1	mesoglycanIBA 01/2015
1	JNJ-39393406IBA 01/2013
1	LeptinIBA 01/2013
1	Carbon MonoxideIBA 04/2012
1	CotinineIBA 04/2012
1	Transcription Factor 4IBA 04/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2011
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 05/2011
1	Amino Acids FDA Link 10/2010
1	Aripiprazole (Abilify)FDA Link 05/2010
1	Dopamine AntagonistsIBA 05/2010
1	Dronabinol (THC)FDA LinkGeneric 08/2009
1	Serotonin (5 Hydroxytryptamine)IBA 04/2009
1	Olanzapine (Zyprexa)FDA Link 08/2008
1	Indicators and Reagents (Reagents)IBA 02/2008
1	Ethanol (Ethyl Alcohol)IBA 12/2006
1	Cholinergic Agents (Cholinergics)IBA 12/2006

Therapy/Procedure

4	Therapeutics 12/2022 - 01/2018
2	Behavior Control 01/2017 - 06/2015
1	Length of Stay 02/2022
1	Cognitive Training 01/2017
1	Drug Therapy (Chemotherapy) 01/2016
1	Opiate Substitution Treatment 05/2014
1	Art Therapy 01/2014